164 related articles for article (PubMed ID: 26839328)
21. The Göttingen minipig for assessment of retinoid efficacy in the skin: comparison of results from topically treated animals with results from organ-cultured skin.
Dame MK; Paruchuri T; DaSilva M; Bhagavathula N; Ridder W; Varani J
In Vitro Cell Dev Biol Anim; 2009 Oct; 45(9):551-7. PubMed ID: 19536603
[TBL] [Abstract][Full Text] [Related]
22. Regulatory acceptability of the minipig in the development of pharmaceuticals, chemicals and other products.
van der Laan JW; Brightwell J; McAnulty P; Ratky J; Stark C;
J Pharmacol Toxicol Methods; 2010; 62(3):184-95. PubMed ID: 20601024
[TBL] [Abstract][Full Text] [Related]
23. From the Cover: The Minipig is a Suitable Non-Rodent Model in the Safety Assessment of Single Stranded Oligonucleotides.
Braendli-Baiocco A; Festag M; Dumong Erichsen K; Persson R; Mihatsch MJ; Fisker N; Funk J; Mohr S; Constien R; Ploix C; Brady K; Berrera M; Altmann B; Lenz B; Albassam M; Schmitt G; Weiser T; Schuler F; Singer T; Tessier Y
Toxicol Sci; 2017 May; 157(1):112-128. PubMed ID: 28123102
[TBL] [Abstract][Full Text] [Related]
24. Pigs in Toxicology: Breed Differences in Metabolism and Background Findings.
Helke KL; Nelson KN; Sargeant AM; Jacob B; McKeag S; Haruna J; Vemireddi V; Greeley M; Brocksmith D; Navratil N; Stricker-Krongrad A; Hollinger C
Toxicol Pathol; 2016 Jun; 44(4):575-90. PubMed ID: 27044377
[TBL] [Abstract][Full Text] [Related]
25. Pimecrolimus: skin disposition after topical administration in minipigs in vivo and in human skin in vitro.
Gschwind HP; Waldmeier F; Zollinger M; Schweitzer A; Grassberger M
Eur J Pharm Sci; 2008 Jan; 33(1):9-19. PubMed ID: 17996430
[TBL] [Abstract][Full Text] [Related]
26. Spontaneous glomerulonephritis in Göttingen minipigs.
Vezzali E; Manno RA; Salerno D; Oberto G; Nyska A; Ramot Y
Toxicol Pathol; 2011 Jun; 39(4):700-5. PubMed ID: 21628719
[TBL] [Abstract][Full Text] [Related]
27. Preclinical safety assessment of a DNA vaccine using particle-mediated epidermal delivery in domestic pig, minipig and mouse.
Dincer Z; Jones S; Haworth R
Exp Toxicol Pathol; 2006 Jul; 57(5-6):351-7. PubMed ID: 16713213
[TBL] [Abstract][Full Text] [Related]
28. Is Science the Only Driver in Species Selection? An Internal Study to Evaluate Compound Requirements in the Minipig Compared to the Dog in Preclinical Studies.
Schaefer K; Rensing S; Hillen H; Burkhardt JE; Germann PG
Toxicol Pathol; 2016 Apr; 44(3):474-9. PubMed ID: 26839331
[TBL] [Abstract][Full Text] [Related]
29. A dermal phototoxicity study following intravenous infusion administration of ciprofloxacin hydrochloride in the novel microminipigs.
Yoshikawa T; Takahashi Y; Kawaguchi H; Utsunomiya S; Miura N; Izumi H; Miyoshi N; Tanimoto A
Toxicol Pathol; 2013 Jan; 41(1):109-13. PubMed ID: 22767873
[TBL] [Abstract][Full Text] [Related]
30. The utility of the minipig as an animal model in regulatory toxicology.
Bode G; Clausing P; Gervais F; Loegsted J; Luft J; Nogues V; Sims J;
J Pharmacol Toxicol Methods; 2010; 62(3):196-220. PubMed ID: 20685310
[TBL] [Abstract][Full Text] [Related]
31. Nonclinical Safety and Toxicokinetics of MnTE-2-PyP (BMX-010), a Topical Agent in Phase 2 Trials for Psoriasis and Atopic Dermatitis.
Gad SC; Sullivan DW; Mujer CV; Spainhour CB; Crapo JD
Int J Toxicol; 2019; 38(4):291-302. PubMed ID: 31333066
[TBL] [Abstract][Full Text] [Related]
32. NTP Toxicology and Carcinogenesis Studies of Triethanolamine (CAS No. 102-71-6) in F344 Rats and B6C3F1 Mice (Dermal Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1999 Nov; 449():1-298. PubMed ID: 12594526
[TBL] [Abstract][Full Text] [Related]
33. The RETHINK project--minipigs as models for the toxicity testing of new medicines and chemicals: an impact assessment.
Forster R; Bode G; Ellegaard L; van der Laan JW;
J Pharmacol Toxicol Methods; 2010; 62(3):158-9. PubMed ID: 20685395
[TBL] [Abstract][Full Text] [Related]
34. Toxicological profile of IQG-607 after single and repeated oral administration in minipigs: An essential step towards phase I clinical trial.
Rodrigues-Junior VS; Cintra L; Machado P; Dadda A; Basso LA; Mafra ACCN; Campos AH; Campos MM; Santos DS
Regul Toxicol Pharmacol; 2017 Nov; 90():78-86. PubMed ID: 28838610
[TBL] [Abstract][Full Text] [Related]
35. Göttingen Minipigs in Ocular Research.
Shrader SM; Greentree WF
Toxicol Pathol; 2018 Jun; 46(4):403-407. PubMed ID: 29683084
[TBL] [Abstract][Full Text] [Related]
36. Use of nontraditional animals for evaluation of pharmaceutical products.
Jacobs A
Expert Opin Drug Metab Toxicol; 2006 Jun; 2(3):345-9. PubMed ID: 16863438
[TBL] [Abstract][Full Text] [Related]
37. Spontaneous background pathology in Göttingen minipigs.
Jeppesen G; Skydsgaard M
Toxicol Pathol; 2015 Feb; 43(2):257-66. PubMed ID: 24939892
[TBL] [Abstract][Full Text] [Related]
38. Plasma pharmacokinetics and distribution of ruxolitinib into skin following oral and topical administration in minipigs.
Persaud I; Diamond S; Pan R; Burke K; Harris J; Conlin M; Yeleswaram S
Int J Pharm; 2020 Nov; 590():119889. PubMed ID: 32949620
[TBL] [Abstract][Full Text] [Related]
39. Swine as models in biomedical research and toxicology testing.
Swindle MM; Makin A; Herron AJ; Clubb FJ; Frazier KS
Vet Pathol; 2012 Mar; 49(2):344-56. PubMed ID: 21441112
[TBL] [Abstract][Full Text] [Related]
40. The minipig in toxicology.
Svendsen O
Exp Toxicol Pathol; 2006 Jul; 57(5-6):335-9. PubMed ID: 16725317
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
